EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC

被引:196
|
作者
DECOCK, KM
ADJORLOLO, G
EKPINI, E
SIBAILLY, T
KOUADIO, J
MARAN, M
BRATTEGAARD, K
VETTER, KM
DOORLY, R
GAYLE, HD
机构
[1] PROJET RETRO CI, ABIDJAN, COTE IVOIRE
[2] EMORY UNIV, SCH PUBL HLTH, ATLANTA, GA 30322 USA
[3] CTR DIS CONTROL & PREVENT, NATL CTR INFECT DIS, DIV HIV AIDS, ATLANTA, GA USA
来源
关键词
D O I
10.1001/jama.270.17.2083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although human immunodeficiency virus type 1 (HIV-1) and HIV-2 share modes of transmission, their epidemiologic characteristics differ and international spread of HIV-2 has been very limited. Recently, the prevalence of infection with HIV-1 but not HIV-2 has increased rapidly in different West African countries, where HIV-2 was probably present earlier. Among 19 701 women of reproductive age tested in Abidjan, Ivory Coast, between 1988 and 1992, the prevalence of HIV-1 infection increased from 5.0% to 9.2%, while that of HIV-2 declined from 2.6% to 1.5%. Differences in viral load may be responsible: reported results of virus culture and polymerase chain reaction assays suggest that at high CD4+ T-lymphocyte counts viral load is lower in HIV-2-infected than in HIV-1-infected persons; the efficacy of heterosexual and perinatal transmission of HIV-2 is less efficient than that of HIV-1 at this stage. At low (<0.20 x 10(9)/L [<200/muL]) CD4+ T-lymphocyte counts, virus isolation is equally successful for both viruses, and the efficacy of heterosexual transmission is similar. Differences in HIV-1 and HIV-2 natural history are reflected in differences in viral load, that for HIV-2 being lower until immunodeficiency is severe. Differences in viral load throughout most of the natural history of infection appear to correlate with lower transmissibility of HIV-2 than HIV-1, and are the likeliest explanation for their markedly different global epidemiology.
引用
收藏
页码:2083 / 2086
页数:4
相关论文
共 50 条
  • [41] Physiopathology of HIV-2 infection
    Visseaux, Benoit
    Le Hingrat, Quentin
    Damond, Florence
    Charpentier, Charlotte
    Descamps, Diane
    VIROLOGIE, 2019, 23 (05) : 277 - 291
  • [42] HIV-2 infection in Thailand
    Chanbancherd, P
    Limpairojn, N
    Benenson, M
    Jugsudee, A
    Julananto, P
    Tienamporn, P
    Luecha, W
    Tasaniyanada, C
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2000, 18 (04): : 245 - 248
  • [43] HIV-2 INFECTION IN AN AMERICAN
    OBRIEN, TR
    POLON, C
    SCHABLE, CA
    VANDEVANTER, N
    RAYFIELD, MA
    WALLACE, D
    STUART, A
    HOLMBERG, SD
    AIDS, 1991, 5 (01) : 85 - 88
  • [44] LEARNING ABOUT HIV-2
    OSHAUGHNESSY, MV
    SCHECHTER, MT
    LANCET, 1994, 344 (8934): : 1380 - 1381
  • [45] Chemokine receptors and HIV-2
    Heredia, A
    Vallejo, A
    Soriano, V
    Epstein, JS
    Hewlett, IK
    AIDS, 1997, 11 (09) : 1198 - 1199
  • [46] DIAGNOSIS OF HIV-2 INFECTION
    不详
    PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT, 1993, 4 (01): : 55 - 55
  • [47] SPREAD OF HIV-2 IN INDIA
    RUBSAMENWAIGMANN, H
    BRIESEN, HV
    MANIAR, JK
    RAO, PK
    SCHOLZ, C
    PFUTZNER, A
    LANCET, 1991, 337 (8740): : 550 - 551
  • [48] ZIDOVUDINE AND HIV-2 DISEASE
    DAWSON, SG
    CHAPEL, HM
    EGLIN, RP
    AIDS, 1990, 4 (09) : 933 - 933
  • [49] HIV-2 IN DJIBOUTI REPUBLIC
    PERRET, JL
    BOUTIER, F
    BARNABE, D
    DEVAUCOULEURS, AB
    MEDECINE ET ARMEES, 1989, 17 (06): : 489 - 489
  • [50] The vpx protein of HIV-2
    Goujon, Caroline
    Darlix, Jean-Luc
    Cimarelli, Andrea
    VIROLOGIE, 2009, 13 (05) : 259 - 269